Cornercap Investment Counsel’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,846
Closed -$141K 661
2023
Q3
$141K Sell
2,846
-37
-1% -$1.83K 0.03% 522
2023
Q2
$225K Buy
2,883
+1,166
+68% +$91.2K 0.04% 494
2023
Q1
$156K Hold
1,717
0.03% 523
2022
Q4
$203K Sell
1,717
-239
-12% -$28.2K 0.04% 517
2022
Q3
$355K Buy
1,956
+496
+34% +$90K 0.07% 431
2022
Q2
$131K Buy
+1,460
New +$131K 0.02% 517